Finder's Pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Mycotopia Therapies is a shell companies business based in the US. Mycotopia Therapies stocks (TWGL.US) are listed on the PINK and all prices are listed in US Dollars. Its last market close was $2.7 – an increase of 1.8% over the previous week. Mycotopia Therapies employs 1 staff and has a market cap (total outstanding stock value) of $54.9 million.
|Latest market close||$1.70|
|52-week range||$1.25 - $9.00|
|50-day moving average||$3.73|
|200-day moving average||$3.11|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.01|
Note: The dollar amounts in the table below are in Canadian dollars.
|1 week (2022-01-17)||N/A|
|1 month (2021-12-24)||N/A|
|3 months (2021-10-24)||N/A|
|6 months (2021-07-24)||N/A|
|1 year (2021-01-28)||-40.35%|
|2 years (2020-01-28)||911.90%|
|3 years (2019-01-28)||580.00%|
|5 years (2017-01-27)||277.78%|
Valuing Mycotopia Therapies stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Mycotopia Therapies's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Mycotopia Therapies's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $70,211.
The EBITDA is a measure of a Mycotopia Therapies's overall financial performance and is widely used to measure a its profitability.
|Gross profit TTM||$0|
|Return on assets TTM||-11.93%|
|Return on equity TTM||-28.43%|
|Market capitalisation||$54.9 million|
TTM: trailing 12 months
We're not expecting Mycotopia Therapies to pay a dividend over the next 12 months.
Mycotopia Therapies's shares were split on a 2:1 basis on 1 May 2014. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Mycotopia Therapies shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Mycotopia Therapies shares which in turn could have impacted Mycotopia Therapies's share price.
Over the last 12 months, Mycotopia Therapies's shares have ranged in value from as little as $1.25 up to $9. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while Mycotopia Therapies's is 5.9937. This would suggest that Mycotopia Therapies's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Mycotopia Therapies Inc. provides psychedelic therapies through technology-focused, data-driven, and medical-based solutions for people dealing with anxiety, depression, bipolar disorders, PTSD, ADHD, autism, and addictions. The company was incorporated in 2019 and is based in Aventura, Florida. The company operates as a subsidiary of EHAVE, Inc. .
Everything we know about the Modular Medical IPO, plus information on how to buy in.
Everything we know about the Direct Digital Holdings IPO, plus information on how to buy in.
Everything we know about the TC BioPharm IPO, plus information on how to buy in.
Everything we know about the Maris-Tech Ltd IPO, plus information on how to buy in.
Everything we know about the Phoenix Motor IPO, plus information on how to buy in.
Everything we know about the Nauticus Robotics, Inc. IPO, plus information on how to buy in.
What is Mogo and how can you access its new trading platform, MogoTrade? Find out in our review.
Lido’s liquid staking allows investors holding LUNA and less than 32 ETH to reap the rewards of DeFi staking.
This guide provides step-by-step instructions on how to buy Convex Finance, lists some exchanges where you can get it and provides daily price data on CVX.
This guide provides step-by-step instructions on how to buy Bitcoin Private, lists some exchanges where you can get it and provides daily price data on BTCP.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.